Blue Horseshoe Stocks: ICLD Recap, Options & More

InterCloud Systems, Inc. ICLD

On Friday we noted that ICLD had rebounded off of its 52-week lows, and directed our readers to pay close attention over ensuing sessions, as the volume had really been ramping up significantly.

This was after tagging the play in our extended watchlist on Thursday We watched as the stock traded as low as .0157 that day and began to gain ground. Yesterday ICLD turned in another strong session to start the week, achieving a new high of .0245. That represents a three-session swing of 56% for this play since we’ve been closely tracking it.

We’ll continue to have ICLD on watch as it both breached through, and closed above its 50DMA yesterday, and its strength index is rising rapidly.


Dish Network Corp. DISH – Options Idea

Standard & Poors revealed late yesterday, that DISH would be added to the S&P500, and this morning, the stock is gapping up moderately in the premarket to the tune of 5%

We want to be standing at the ready with a solid options play, should the bullish activity carry over into today’s session, so we’re going to identify the DISH Weekly $63-65 Calls as targets for potential intraday/intraweek flip opportunities.


Extended Watchlist:
DRYS, WFT, MOMO, MYSZ, PBR, AF, TXHD, PPHM

Blue Horseshoe Stocks: New Highs for OWCP, VDRM & More

OWC Pharmaceutical Research Corp. OWCP – Update

Our readers might have had to do a double-take when we reported our observed range on OWCP leading into yesterday’s session, which was a record-setting 57,956% from the low we saw subsequent to alerting the stock in our premarket report from September 29th (.0036).

We upped the ante even further, stating that “we wouldn’t even be surprised to see our unreal observed range extended even further over coming sessions.”

Sure enough, the stock once again set new highs, trading in a daily range from 2.16 to 3.23 on monstrous volume; good for intraday gains of up to 50% But hold onto your hats, folks, because that new high tabulates to an overall increase of 89,622% in the span of less than four months!

It’s the largest gain of any pick we’ve ever issued, and may hold that record for quite some time, so we just have to give ourselves a huge pat on the back! As to anyone who was along for this ride that had the potential to spawn new millionaires, we salute you as well!


ViaDerma, Inc. VDRM

In terms of alerts that originated in 2017, VDRM is one of our top performers. The stock traded with some excellent price action and volatility yesterday after we included it in our morning report.

There was an early run from .0375 to .065, which works out to an intraday pop of 73% and that was followed by a dip-and-rip from .0376 to a strong close at .0625 (+66%).

Far more impressive is the total amount of ground VDRM has covered since our alert on the stock from January 13th, at which time it was trading at a low of .0048. While it’s peanuts compared to the previously mentioned play, in and of itself, a gain of 1254% in less than six weeks is definitely something special!


Extended Watchlist:
BTX, PPHM, THCT, PURA, KGKG,
CETX(Bottom-Watch)

Incoming search terms:

  • owcp stock forum
  • kadgkgtag

Blue Horseshoe Stocks: The Incredible Run of OWCP & More

OWC Pharmaceutical Research Corp. OWCP

Our primary order of business this morning is to do a nice recap of what is perhaps the most profit-potential-packed pick in the long history of our newsletter’s existence! We’ve had percentage gainers of 5,000, 10,000 with relative regularity- and even the occasional 20,000 percenter- but nothing even approaching the move we’ve witnessed since tagging OWCP as a bottom play this fall, in our premarket report from September 29th.

The climb from the .0036 low we observed that morning would have been difficult to fathom at the time, but over the next four months, it has gone on to impress in a monumental way. Despite slight consolidations along the way, OWCP has persisted through multiple patches of resistance in arriving at yesterday’s new high of 2.10, marking a ridiculous overall run of 57,956%

Considering the fantastic bullish close the stock had yesterday, we wouldn’t even be surprised to see our unreal observed range extended even further over coming sessions.


Wal-Mart Stores, Inc. WMT – Options Update

In yesterday’s premarket report, we updated readers on our WMT options idea from January 31st. We were looking for an extended-term rebound when we signaled the WMT 03/03 $68-$69.50 Calls, and that’s exactly what we’ve gotten.

Leading into yesterday’s session we touted the excellent gain opportunities we had seen to that point in our selected contracts, which ranged from 166-246% We also made it a point to caution that with the way the stock was behaving in the premarket, we expected to see those ranges extended in a significant manner.

As you can see from updated figures below, the overall ranges on our observed plays were more than doubled with yesterday’s activity:

$68 Calls – Range: .86-4.20 – Max Gain: 388%
$68.50 Calls – Range: .57-3.75 – Max Gain: 558%
$69 Calls – Range: .48-3.25 – Max Gain: 577%
$69.50 Calls – Range: .41-2.75 – Max Gain: 570%

______

FRESH OPTIONS IDEA:

Garmin Ltd. GRMN – On the heels of it’s impressive earnings beat, we’re going to tag the GRMN 03/17 $52.50-60 Calls for observation this morning.


Extended Watchlist:
PPHM, OXIHF, VDRM, MJTK, TOL

Incoming search terms:

  • stocks owcp

Blue Horseshoe Stocks: NFLX, MCD Options Recaps & More

Options Recaps

Netflix, Inc. NFLX – We persisted in tracking the NFLX options idea that we formulated on Tuesday for the remainder of the week, and they ended up performing great yet again on Friday.  If you recall, our designated targets were the NFLX Weekly $117-120 Calls, and they didn’t have a down day all week.

The following figures indicate the lows we observed on Tuesday morning, and the subsequent highs reached during Friday’s session. What we were faced with were four incredible intraweek increases:

$117 Calls – Range: 2.19-10.77 – Max Gain: 392%
$118 Calls – Range: 1.43-10.02 – Max Gain: 601%
$119 Calls – Range: 1.03-8.87 – Max Gain: 761%
$120 Calls – Range: 1.07-7.83 – Max Gain: 631%

______

 McDonalds Corp. MCD - Our highlighted range of MCD Weekly $113-115 Calls was fresh for Friday’s session, and it bore fruit as well. While we didn’t sweep the range in terms of hefty gains, the $113′s in particular did provide a nice chance to profit on the day.

Those calls traded in a range from .33 and shot to 1.43, allowing for  single-session gains of up to 333%


Agritek Holdings, Inc. AGTK 

Subsequent to the alert we put out on AGTK last month on the 14th, we would observe an overall low of .003, and the stock has never fallen below that level since. In fact, what began as a subpenny play, has rumbled its way to multiple pennies after a fantastic performance last week.

Running to a new high of .0298 on Friday, the stock registered an overall increase of 893% over our observed low, and with a strong close at .028, we’ll be on the lookout for some momentum spillover into this week. The possibility of a dip-and-rip forming on the chart also appears to be a plausible scenario, so we’ll be on our toes watching for that possibility as well.

AGTK is also a part of the cannabis sector, which of course we’ve been watching more intently, and plan to continue doing so leading into election day the week after next.


Peregrine Pharmaceuticals, Inc. PPHM

This is another familiar play for us, and we want to tag it for closer observation again this morning on the strength of both a fresh PR hitting the wires along with an attractive technical setup on the chart.

As you can see below, the stock has recorded a higher low in each of the last five sessions since coming off a bottom, and indicators suggest that things could heat up for this play at any time. We’ll keep an eye peeled.

TODAY’S NEWS:
Preclinical Research Demonstrates Peregrine Pharmaceuticals’ PS-Targeting Antibodies Enhance the Anti-Tumor Activity of PD-L1 Checkpoint Inhibitors in Model of Triple Negative Breast Cancer (TNBC)(>>Read PR)


Extended Watchlist:
IFAN, PLPL, PPCH, PPJE, OPGN, DRWI, NEWC, VNTH

Blue Horseshoe Stocks: Updates, Fresh Plays & More

Kraig Biocraft Laboratories, Inc. KBLB

We alerted KBLB in Wednesday morning’s premarket report, and on that day, we would observe a PPS low of .0261. Yesterday, the stock hit a high of .0395, for a respectable two-session upswing of 51%

Following that solid run-up, we saw the stock close at .0375, maintaining a vast majority of its advance. We’ll continue to keep a steady eye on KBLB, and look for it to maintain support above the .03-mark in order to keep us interested.


Potential Bottom-Plays

Rennova Health, Inc. RNVA – We have an interesting story unfolding with RNVA, and a potential rebound opportunity as well. After briefly cracking its 50DMA on Wednesday, the stock took a major gut punch yesterday as it gapped down immensely.

It seems a bit of an overreaction after reading the PR that apparently catalyzed the selloff. The company announced yesterday that it had priced a public offering with the intent of raising upwards of $8.6M in capital, expected to close by Tuesday. They set the purchase price at .45, which is why a massive slide to less than .30 seemed disproportionate.

We’ll be interested to see the activity in this now majorly-oversold stock in sessions to come.


__________

Ampio Pharmaceuticals, Inc. AMPE
– Speaking of stocks that have recently gapped down hard and found new lows, we have AMPE hitting our bottom-play radar.

Similar to the aforementioned play, the selloff occurred as a result of what some might construe as over-reactive. The company released data from a clinical study at the end of last month on its osteoarthritis injection treatment that was poorly-received.  However, while the primary endpoints of the double-blind study were not met, the treatment was markedly effective in improving the patients with the most extreme cases of the condition.

So the study was not a total loss, and the company made clear its intent to submit an FDA application for the treatment for those severely afflicted patients that were helped, and for whom no other non-surgical alternative exists.

That’s why we’ll be keeping an eye on AMPE to continue to regain some of its lost ground, as it has done over the past few sessions.


Extended Watchlist:
MAXD, MFST, PPHM, FES, SPU, KURA, COSI(Bottom watch)

Incoming search terms:

  • thefloorfeed com